EN
HI
Summary
As of 6 Oct, 2026, Concord Drugs stock price is ₹73. During the trading session, the stock has moved between an intraday low of ₹72.35 and an intraday high of ₹76.84. Over the last 52 weeks, Concord Drugs has traded between ₹61.00 and ₹92.52.
The stock has recorded a trading volume of 18,706 shares,. Its Average Traded Price (ATP) is ₹73.49, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 100 @ ₹73.00.
Concord Drugs has an upper circuit limit of ₹92.30 and a lower circuit limit of ₹61.54. The total value traded stands at ₹13.75 L, and the delivery percentage for the day is 81.82%.
The stock is currently traded with a market lot size of 1. Concord Drugs also offers a dividend yield of 0%.
Concord Drugs Share Price Chart
Concord Drugs Share Key Metrics
Volume
18706.00
Market Cap
96.22 CR
LTQ@LTP
100@73.00
ATP
73.49
Var Margin
25 %
Circuit Range
61.54-92.3
Delivery %
81.82 %
Value
13.75 L
ASM/GSM
No
Market Lot
1
Concord Drugs Fundamentals
P/E Ratio
49.41
P/B Ratio
2.04
Div. Yield
0
Sector P/E
42.19
Sector P/B
3.53
Sec. Div. Yield
0.52
Concord Drugs Resistance and Support
Pivot 76.88
Resistance
First Resistance
78.82
Second Resistance
80.73
Third Resistance
82.67
Support
First Support
74.97
Second Support
73.03
Third Support
71.12
Concord Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Oct 06 2026 | 76.84 | 73 | -5.08% | 76.84 | 72.35 |
| Mon Oct 05 2026 | 74.94 | 76.91 | 1.61% | 78.79 | 74.94 |
| Thu Oct 01 2026 | 73.05 | 75.69 | 1.57% | 76.87 | 71.15 |
Concord Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-07-03 | Preferential issue of shares |
| 2025-06-27 | Preferential Issue of shares & Others |
| 2025-05-23 | Audited Results |
| 2025-03-17 | Preferential Issue of shares & Others |
| 2025-03-13 | Preferential Issue of shares & Others |
| 2025-01-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Drugs News
Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Concord Drugs Limited has submitted the Scrutinizer's Report and Voting Results for the 31st AGM held on 30.09.2026. All resolutions were approved.
Oct 01 2026 13:36:44
Concord Drugs Ltd - 538965 - Intimation Of Record Date For 31St AGM
Concord Drugs has fixed September 23, 2026, as the record date. This is to determine the shareholders eligible for e-voting at its 31st Annual General Meeting, scheduled for September 30, 2026.
Sep 07 2026 19:28:01
Read More
Concord Drugs Management
| Name | Position |
|---|---|
| S Nagi Reddy | Chairman & Managing Director |
| S Koni Reddy | Whole Time Director & Chief Financial Officer |
Concord Drugs Similar Stocks
Himalaya Nutravedics India Ltd.
135.00
6.30 (4.90%)
Bharat Immunologicals & Biologicals Corporation Ltd.
8.28
0.75 (9.96%)
Makers Laboratories Ltd.
183.00
2.65 (1.47%)
Asston Pharmaceuticals Ltd.
97.35
-0.65 (0.66%)
Pharmaids Pharmaceuticals Ltd.
30.48
0.33 (1.09%)
Everest Organics Ltd.
249.00
13.00 (5.51%)
Godavari Drugs Ltd.
119.00
2.30 (1.97%)
Kretto Syscon Ltd.
0.41
0.00 (0.00%)
Vasundhara Rasayans Ltd.
151.40
2.60 (1.75%)
Concord Drugs FAQs
The Buying Price of Concord Drugs share is 73 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Drugs shares is 49.41. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Drugs shares is 2.04. Useful to assess the stock's value relative to its book value.
To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 42.19 & 3.53 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Drugs is 96.22 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Drugs share price is 92.52 & 61.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CONCORD
